Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

HER2-positive advanced breast cancer.

Nicholas J Robert1, Anne M Favret

  • 1US Oncology Research Network, Fairfax Northern Virginia Hematology Oncology, 8503 Arlington Boulevard, #400, Fairfax, VA 22031, USA. nicholas.robert@usoncology.com

Hematology/Oncology Clinics of North America
|May 22, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Directly comparing randomized and real-world controls in adjuvant breast cancer.

Journal of comparative effectiveness research·2026
Same author

Biomarker Testing Rates and Patterns in Patients With Metastatic Non-Small Cell Lung Cancer: A Prospective, Observational Study in Community Practices.

JCO precision oncology·2026
Same author

Emulating Comparative Oncology Trials With Real-World Evidence Studies (ENCORE): Process Development and Methodological Considerations for Oncology Real-World Data.

Clinical pharmacology and therapeutics·2026
Same author

Impact of an Oncology Clinical Pharmacist Intervention on Clinical Trial Enrollment in The US Oncology Network's MYLUNG Consortium.

Journal of the advanced practitioner in oncology·2025
Same author

Which social determinants of health have the highest impact in community oncology to advance patient care equity and improve health outcomes? A scoping review.

Cancer medicine·2024
Same author

Evaluation of Real-World Tumor Response Derived From Electronic Health Record Data Sources: A Feasibility Analysis in Patients With Metastatic Non-Small Cell Lung Cancer Treated With Chemotherapy.

JCO clinical cancer informatics·2024

Evaluating human epidermal growth factor receptor 2 (HER2) status is crucial for advanced breast cancer treatment. Understanding HER2 biology and therapies optimizes patient management and improves outcomes.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Advanced breast cancer treatment requires understanding tumor biology.
  • Hormone receptor status (estrogen, progesterone) is standard.
  • Human epidermal growth factor receptor 2 (HER2) is a key biomarker.

Purpose of the Study:

  • To review the biology of HER2 in breast cancer.
  • To discuss HER2 testing methodologies.
  • To evaluate HER2-targeted therapies and their associated side effects.

Main Methods:

  • Literature review of HER2 biology.
  • Analysis of clinical studies on HER2-based therapies.
  • Examination of HER2 testing guidelines and outcomes.

Related Experiment Videos

Main Results:

  • HER2 status significantly impacts treatment selection.
  • HER2-targeted therapies have shown efficacy in HER2-positive cancers.
  • Cardiotoxicity is a notable side effect of some HER2 therapies.

Conclusions:

  • Accurate HER2 testing is essential for personalized breast cancer treatment.
  • HER2-based therapies offer improved outcomes for eligible patients.
  • Monitoring for and managing side effects like cardiotoxicity is critical.